4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001062993-24-015385
Options or other derivatives
- Chief Executive Officer acquired 145,952 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelderman Kim Chief Executive Officer | 2024-08-15 | Grant or award · Performance Restricted Stock Units | +51,261 | 51,261 | D | ||
| Kelderman Kim Chief Executive Officer | 2024-08-15 | Grant or award · Restricted Stock Units | +25,630 | 25,630 | D | ||
| Kelderman Kim Chief Executive Officer | 2024-08-15 | Grant or award · Stock Options (Right to Buy) | +69,061 | 69,061 | D | ||
Loading xslF345X05/form4.xml…